PDB15- COST-EFFECTIVENESS ANALYSIS OF GRAFTSKIN (APLIGRAF) AND BECAPLERMIN (REGRANEX) IN DIABETIC NEUROPATHIC FOOT ULCERS
May 1, 2003, 00:00
10.1016/S1098-3015(10)64180-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64180-0/fulltext
Title :
PDB15- COST-EFFECTIVENESS ANALYSIS OF GRAFTSKIN (APLIGRAF) AND BECAPLERMIN (REGRANEX) IN DIABETIC NEUROPATHIC FOOT ULCERS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64180-0&doi=10.1016/S1098-3015(10)64180-0
First page :
Section Title :
Open access? :
No
Section Order :
380